These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5098670)

  • 1. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization.
    Finklea JF; Hasselblad V; Riggan WB; Nelson WC; Hammer DI; Newill VA
    Am Rev Respir Dis; 1971 Sep; 104(3):368-76. PubMed ID: 5098670
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66.
    Stuart WH; Dull HB; Newton LH; McQueen JL; Schiff ER
    JAMA; 1969 Jul; 209(2):232-8. PubMed ID: 5819227
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines.
    Mogabgab WJ; Leiderman E
    JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268
    [No Abstract]   [Full Text] [Related]  

  • 7. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Persistence of antibodies inhibiting hemagglutination by influenza viruses in aged vaccinated women. Changes in antibody titer after re-vaccination].
    Visconti M; Verde F; Frezza G; Russo V
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):173-7. PubMed ID: 4779760
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of inactivated influenza vaccine to protect an aged population.
    D'Alessio DJ; Cox PM; Dick EC
    JAMA; 1969 Oct; 210(3):485-9. PubMed ID: 5394377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serological response to anti-influenza booster vaccination in a group of aged subjects].
    Crovari-Cuneo P; De Flora S; Vannucci A; Badolati G
    G Ig Med Prev; 1967; 8(5):623-30. PubMed ID: 5605876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Persistence of anti-V hemagglutination-inhibiting antibodies and complement-fixing antibodies induced by administration of inactivated influenza vaccines].
    Profeta ML
    Ann Sclavo; 1972; 14(2):145-58. PubMed ID: 4669354
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.
    Meier S; Bel M; L'huillier A; Crisinel PA; Combescure C; Kaiser L; Grillet S; Pósfay-Barbe K; Siegrist CA;
    Vaccine; 2011 Apr; 29(19):3548-57. PubMed ID: 21419775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity in medical students of current programs for influenza vaccination.
    Berlin BS
    J Am Coll Health Assoc; 1972 Apr; 20(4):241-5. PubMed ID: 5017983
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody against influenza A2 virus neuraminidase in human sera.
    Schild GC
    J Hyg (Lond); 1969 Jun; 67(2):353-65. PubMed ID: 5256462
    [No Abstract]   [Full Text] [Related]  

  • 19. Hong Kong influenza immunologic recapitulation.
    Marine WM; Workman WM
    Am J Epidemiol; 1969 Nov; 90(5):406-15. PubMed ID: 5356948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibody response after anti-influenza vaccination in a closed community and protective effect against the disease].
    Scalise G; Maida A; Mura MS; Pettinato S; Mura M
    Ann Sclavo; 1974; 16(3):243-60. PubMed ID: 4429406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.